Back to Results
First PageMeta Content
Angiotensin II receptor antagonists / Carboxylic acids / Tetrazoles / Candesartan / Ethers / Pharmacometrics / Antihypertensive drug / Clinical trial / Methadone / Chemistry / Organic chemistry / Pharmacology


020838_Candesartan_Clinpharm_BPCA
Add to Reading List

Open Document

File Size: 991,22 KB

Share Result on Facebook

Company

BP / AstraZeneca / ITT / Clinical Pharmacology I / /

Country

United States / /

Event

FDA Phase / /

IndustryTerm

treatment of hypertension / /

MedicalCondition

Hypertension / Pediatric Hypertension / disease / obesity / renal disease / deficiency / Regimen Hypertension / QD (starting) Heart failure / /

Organization

OND Division Division of Cardiovascular / Proposed Dosing Regimen OCP Division / /

Person

Issam Zineh / Rajanikanth Madabushi / Lee / Jiang Liu / Jeanne Fourie / Pharmacometrics Reviewer Jiang Liu / Ora-Plus / Robert Kumi / Ting Ong / Lawrence Lesko / Bei Yu / R. Younis / Gilbert Burckhart / Norman Stockbridge / Kellie Reynolds / Mei Huang / Suchitra / Brian Booth / John Lazer / Mehul Mehta / Larry Lesko / Pravin Jadhav / Christian Grimstein / /

Position

Team Leader / Executive / Major / General / /

Product

Candesartan cilexetil / Oral tablet / Atacand / SE5 / S031 / Atacand® / Adults / United States / submission / /

Technology

Pharmacokinetics / /

SocialTag